Madison Covered Call & Equity Income Fund Class R6
MENRX
NASDAQ
| Weiss Ratings | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Good | |||
| Risk Grade | B | |||
| Company Info | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Madison Funds | |||
| Manager/Tenure (Years) | Ray DiBernardo (16), Drew Justman (9) | |||
| Website | http://www.madisonfunds.com | |||
| Fund Information | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Madison Covered Call & Equity Income Fund Class R6 | |||
| Category | Derivative Income | |||
| Sub-Category | Equity Miscellaneous | |||
| Prospectus Objective | Equity-Income | |||
| Inception Date | Jul 31, 2012 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 500,000.00 | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 8.42% | |||
| Dividend | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 2.40% | |||
| Asset Allocation | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 8.53% | |||
| Stock | 91.47% | |||
| U.S. Stock | 90.00% | |||
| Non-U.S. Stock | 1.47% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.50% | |||
| 30-Day Total Return | 5.87% | |||
| 60-Day Total Return | 1.08% | |||
| 90-Day Total Return | 3.47% | |||
| Year to Date Total Return | 9.82% | |||
| 1-Year Total Return | 12.89% | |||
| 2-Year Total Return | 14.79% | |||
| 3-Year Total Return | 28.45% | |||
| 5-Year Total Return | 41.63% | |||
| Price | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $9.92 | |||
| 1-Month Low NAV | $9.35 | |||
| 1-Month High NAV | $9.92 | |||
| 52-Week Low NAV | $9.19 | |||
| 52-Week Low NAV (Date) | Jun 30, 2026 | |||
| 52-Week High NAV | $10.14 | |||
| 52-Week High Price (Date) | Feb 27, 2026 | |||
| Beta / Standard Deviation | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.36 | |||
| Standard Deviation | 9.66 | |||
| Balance Sheet | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 125.06M | |||
| Operating Ratios | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.90% | |||
| Turnover Ratio | 78.00% | |||
| Performance | MENRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 22.13% | |||
| Last Bear Market Total Return | -8.45% | |||